134 related articles for article (PubMed ID: 31364651)
1. The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy.
Li J; Chen L; Su H; Yan L; Gu Z; Chen Z; Zhang A; Zhao F; Zhao Y
Nanoscale; 2019 Aug; 11(31):14528-14539. PubMed ID: 31364651
[TBL] [Abstract][Full Text] [Related]
2. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.
Meng J; Wang DL; Wang PC; Jia L; Chen C; Liang XJ
J Nanosci Nanotechnol; 2010 Dec; 10(12):8610-6. PubMed ID: 21121373
[TBL] [Abstract][Full Text] [Related]
3. A Novel Drug Design Strategy: An Inspiration from Encaging Tumor by Metallofullerenol Gd@C
Li J; Chen L; Yan L; Gu Z; Chen Z; Zhang A; Zhao F
Molecules; 2019 Jun; 24(13):. PubMed ID: 31252662
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Yin JJ; Lao F; Meng J; Fu PP; Zhao Y; Xing G; Gao X; Sun B; Wang PC; Chen C; Liang XJ
Mol Pharmacol; 2008 Oct; 74(4):1132-40. PubMed ID: 18635669
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.
Kang SG; Araya-Secchi R; Wang D; Wang B; Huynh T; Zhou R
Sci Rep; 2014 Apr; 4():4775. PubMed ID: 24758941
[TBL] [Abstract][Full Text] [Related]
6. Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor.
Liu Y; Chen C; Qian P; Lu X; Sun B; Zhang X; Wang L; Gao X; Li H; Chen Z; Tang J; Zhang W; Dong J; Bai R; Lobie PE; Wu Q; Liu S; Zhang H; Zhao F; Wicha MS; Zhu T; Zhao Y
Nat Commun; 2015 Jan; 6():5988. PubMed ID: 25612916
[TBL] [Abstract][Full Text] [Related]
7. The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C
Wang X; Yang N; Su J; Wu C; Liu S; Chang L; Plant LD; Meng X
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053271
[TBL] [Abstract][Full Text] [Related]
8. Biological characterizations of [Gd@C82(OH)22]n nanoparticles as fullerene derivatives for cancer therapy.
Meng J; Liang X; Chen X; Zhao Y
Integr Biol (Camb); 2013 Jan; 5(1):43-7. PubMed ID: 22961501
[TBL] [Abstract][Full Text] [Related]
9. Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1.
Pan Y; Wang L; Kang SG; Lu Y; Yang Z; Huynh T; Chen C; Zhou R; Guo M; Zhao Y
ACS Nano; 2015 Jul; 9(7):6826-36. PubMed ID: 26083726
[TBL] [Abstract][Full Text] [Related]
10. Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice.
Wang J; Chen C; Li B; Yu H; Zhao Y; Sun J; Li Y; Xing G; Yuan H; Tang J; Chen Z; Meng H; Gao Y; Ye C; Chai Z; Zhu C; Ma B; Fang X; Wan L
Biochem Pharmacol; 2006 Mar; 71(6):872-81. PubMed ID: 16436273
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis through ER stress and TP53 in MCF-7 cells by the nanoparticle [Gd@C82(OH)22]n: A systems biology study.
Wang L; Meng J; Cao W; Li Q; Qiu Y; Sun B; Li LM
Methods; 2014 Jun; 67(3):394-406. PubMed ID: 24440483
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of Gd@C
Liu J; Kang SG; Wang P; Wang Y; Lv X; Liu Y; Wang F; Gu Z; Yang Z; Weber JK; Tao N; Qin Z; Miao Q; Chen C; Zhou R; Zhao Y
Biomaterials; 2018 Jan; 152():24-36. PubMed ID: 29080421
[TBL] [Abstract][Full Text] [Related]
13. Metallofullerenol Inhibits Cellular Iron Uptake by Inducing Transferrin Tetramerization.
Li J; Xing X; Sun B; Zhao Y; Wu Z
Chem Asian J; 2017 Oct; 12(20):2646-2651. PubMed ID: 28815927
[TBL] [Abstract][Full Text] [Related]
14. Gd-Metallofullerenol nanoparticles cause intracellular accumulation of PDGFR-α and morphology alteration of fibroblasts.
Tang J; Guo M; Wang P; Liu J; Xiao Y; Cheng W; Gao J; Hu W; Miao QR
Nanoscale; 2019 Mar; 11(11):4743-4750. PubMed ID: 30604821
[TBL] [Abstract][Full Text] [Related]
15. Impacts of fullerene derivatives on regulating the structure and assembly of collagen molecules.
Yin X; Zhao L; Kang SG; Pan J; Song Y; Zhang M; Xing G; Wang F; Li J; Zhou R; Zhao Y
Nanoscale; 2013 Aug; 5(16):7341-8. PubMed ID: 23820497
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine.
Kang SG; Zhou G; Yang P; Liu Y; Sun B; Huynh T; Meng H; Zhao L; Xing G; Chen C; Zhao Y; Zhou R
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15431-6. PubMed ID: 22949663
[TBL] [Abstract][Full Text] [Related]
17. Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities.
Wu G; Gao XJ; Jang J; Gao X
J Mol Model; 2016 Jul; 22(7):161. PubMed ID: 27316702
[TBL] [Abstract][Full Text] [Related]
18. Metallofullerenol Gd@C₈₂(OH)₂₂ distracts the proline-rich-motif from putative binding on the SH3 domain.
Kang SG; Huynh T; Zhou R
Nanoscale; 2013 Apr; 5(7):2703-12. PubMed ID: 23423582
[TBL] [Abstract][Full Text] [Related]
19. Subcellular distribution of polyhydroxylated metallofullerene Gd@C82(OH)22 in different tissues of tumor-bearing mice.
Zhou G; Li Y; Liu Y; Ge C; Li W; Sun B; Li B; Gao Y; Chen C
J Nanosci Nanotechnol; 2010 Dec; 10(12):8597-602. PubMed ID: 21121371
[TBL] [Abstract][Full Text] [Related]
20. Charging nanoparticles: increased binding of Gd@C
Chen SH; Kang SG; Luo J; Zhou R
Nanoscale; 2018 Mar; 10(12):5667-5677. PubMed ID: 29528358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
